Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II placebo-controlled dose-exploration study of 香芩解热颗粒 in adults with influenza (damp-heat exterior syndrome)
CTR20253678Phase 2Active
- Sponsor
- Yunnan Fangsheng Ronghe Pharmaceutical
- Start
- Nov 2025
- Countries
- 1
01
Overview
A Phase 2 trial of Xiangqin Jiere Granules in influenza, sponsored by Yunnan Fangsheng Ronghe Pharmaceutical. Started Nov 2025; status: active.
02
Drugs
Xiangqin Jiere Granules
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20253678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253678.